Illumina has appointed Charles Dadswell as its new senior vice president and general counsel. Dadswell replaces Christian Cabou, who has retired, and is responsible for all of the company's legal and IP matters.

Illumina has named Paul Bianchi as its senior vice president of human resources. In his new role, Bianchi will oversee Illumina's global HR strategy and will manage the San Diego firm's office in Hayward, Calif.

The instrument will be the second Aushon printer the institution has obtained for its Functional Proteomics Reverse Phase Protein Array Facility.

The UK firm has decided to offer custom array printing services to meet demand from customers who do not wish to buy their own arrayers, as well as those who want to try its arrayers before bringing a system in house.

New Product Watch


Ocimum Biosolutions' microRNA OciChips, Aushon Biosystems' Human Nephrotoxicity Panels

The program will consist of miniaturized RNAi screens, and in the future will include compound/drug arrays.

The project included constructing new lab and manufacturing areas and relocating existing SearchLight personnel and its Clinical Laboratory Improvement Act-compliant laboratory operations.

BioArray Briefs


Baylor College of Medicine, Illumina, Aushon Biosystems, SciGene, Invitrogen

Aushon said the funds were used partly to fund the acquisition of Thermo Fisher's SearchLight Protein Array business.

Aushon adds the protein array technologies and service capabilities to its portfolio of microarray products. It will continue to sell the acquired business' products under the SearchLight brand.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.